CAY10508 – 10 mg

Brand:
Cayman
CAS:
878533-35-8
Storage:
-20
UN-No:
Non-Hazardous - /

Central cannabinoid (CB1) receptor antagonists and inverse agonists exhibit therapeutic potential for obesity and drug dependence, while being devoid of psychotropic effects. CAY10508 is a potent and selective central cannabinoid (CB1) receptor inverse agonist with a Ki value of 243 nM and an EC50 of 195 nM.{14135} A 10 µM concentration of CAY10508 resulted in 100% and 35% displacement of [3H]-CP-55,940 at the CB1 and peripheral cannabinoid (CB2) receptors, respectively. A [35S]-GTPγS binding assay revealed the inverse agonist properties of CAY10508 at the CB1 receptor.  

 

Available on backorder

SKU: 10008669 - 10 mg Category:

Description

A potent and selective CB1 receptor inverse agonist (Ki = 243 nM; EC50 = 195 nM); a 10 µM concentration results in 100% and 35% displacement of [3H]-CP-55,940 at the CB1 and CB2 receptors, respectively


Formal name: 1,3-bis(4-bromophenyl)-5-phenyl-2,4-imidazolidinedione

Synonyms: 

Molecular weight: 486.2

CAS: 878533-35-8

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Inverse Agonists||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors